TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin
Sensing of pathogens by Toll-like receptor 4 (TLR4) induces an inflammatory response; controlled responses confer immunity but uncontrolled responses cause harm. Here we define how a multimodular scaffold, GIV (a.k.a. Girdin), titrates such inflammatory response in macrophages. Upon challenge with e...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 117; no. 43; pp. 26895 - 26906 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
27.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Sensing of pathogens by Toll-like receptor 4 (TLR4) induces an inflammatory response; controlled responses confer immunity but uncontrolled responses cause harm. Here we define how a multimodular scaffold, GIV (a.k.a. Girdin), titrates such inflammatory response in macrophages. Upon challenge with either live microbes or microbe-derived lipopolysaccharides (a ligand for TLR4), macrophages with GIV mount a more tolerant (hypo-reactive) transcriptional response and suppress proinflammatory cytokines and signaling pathways (i.e., NFkB and CREB) downstream of TLR4 compared to their GIV-depleted counterparts. Myeloid-specific gene-depletion studies confirmed that the presence of GIV ameliorates dextran sodium sulfate-induced colitis and sepsis-induced death. The antiinflammatory actions of GIV are mediated via its C-terminally located TIR-like BB-loop (TILL) motif which binds the cytoplasmic TIR modules of TLR4 in a manner that precludes receptor dimerization; such dimerization is a prerequisite for proinflammatory signaling. Binding of GIV’s TILL motif to TIR modules inhibits proinflammatory signaling via other TLRs, suggesting a convergent paradigm for fine-tuning macrophage inflammatory responses. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by Shizuo Akira, Osaka University, Osaka, Japan, and approved September 18, 2020 (received for review June 10, 2020) Author contributions: L.S., G.D.K., S.D., and P.G. designed research; L.S., G.D.K., J.T., R.F.P., Y.C., J.C., M.S.A., V.C., J.O., and I.K. performed research; S.D. supervised all experiments with live microbes; V.N., I.K., and S.D. contributed new reagents/analytic tools; L.S., G.D.K., J.T., R.F.P., Y.C., J.C., M.S.A., V.C., I.K., S.D., and P.G. analyzed data; and L.S., I.K., and P.G. wrote the paper. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.2011667117 |